Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
HKSE - Delayed Quote HKD

Genor Biopharma Holdings Limited (6998.HK)

Compare
1.910
-0.010
(-0.52%)
As of 2:00:54 PM GMT+8. Market Open.
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
15,932
--
10,331
Cost of Revenue
--
--
983
--
2,596
Gross Profit
--
--
14,949
--
7,735
Operating Expense
689,515
689,515
801,154
918,671
932,156
Operating Income
-689,515
-689,515
-786,205
-918,671
-924,421
Net Non Operating Interest Income Expense
28,630
28,630
25,099
21,119
-1,944
Pretax Income
-677,496
-677,496
-732,420
-866,306
-3,036,310
Tax Provision
-2,280
-2,280
-2,024
-932
-5,806
Net Income Common Stockholders
-674,362
-674,362
-730,214
-865,224
-3,027,102
Average Dilution Earnings
--
--
-998
-11,278
--
Diluted NI Available to Com Stockholders
-674,362
-674,362
-730,214
-876,502
-3,027,102
Basic EPS
-1.33
-1.33
-1.45
-1.75
-12.36
Diluted EPS
-1.33
-1.33
-1.45
-1.77
-12.36
Basic Average Shares
506,245
506,245
504,301
495,180
244,890
Diluted Average Shares
506,245
506,245
504,301
496,203
244,890
Total Operating Income as Reported
-711,196
-711,196
-782,719
-859,107
-2,903,022
Total Expenses
689,515
689,515
802,137
918,671
934,752
Net Income from Continuing & Discontinued Operation
-674,362
-674,362
-730,214
-865,224
-3,027,102
Normalized Income
-665,470.026
-665,470.026
-730,214
-865,224
-3,026,552.054
Interest Income
29,669
29,669
28,114
23,729
3,715
Interest Expense
888
888
2,856
2,362
5,539
Net Interest Income
28,630
28,630
25,099
21,119
-1,944
EBIT
-676,608
-676,608
-729,564
-863,944
-3,030,771
EBITDA
-599,721
-599,721
-675,887
-803,199
-2,980,286
Reconciled Cost of Revenue
--
--
983
--
2,596
Reconciled Depreciation
76,887
76,887
53,677
60,745
50,485
Net Income from Continuing Operation Net Minority Interest
-674,362
-674,362
-730,214
-865,224
-3,027,102
Total Unusual Items Excluding Goodwill
-8,922
-8,922
--
16,302
-551
Total Unusual Items
-8,922
-8,922
--
16,302
-551
Normalized EBITDA
-590,799
-590,799
-675,887
-803,199
-2,979,735
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-30.026
-30.026
--
--
-1.054
12/31/2020 - 10/7/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

688578.SS Shanghai Allist Pharmaceuticals Co., Ltd.
77.00
+3.01%
 
4587.T PeptiDream Inc.
2,116.00
+1.15%
 
6855.HK Ascentage Pharma Group International
39.200
-5.43%
 
2197.HK Clover Biopharmaceuticals, Ltd.
0.325
-2.99%
 
AVTE Aerovate Therapeutics, Inc.
2.3700
-0.84%
 
ENZN Enzon Pharmaceuticals, Inc.
0.1300
0.00%
 
6996.HK Antengene Corporation Limited
2.080
+1.46%
 
9939.HK Kintor Pharmaceutical Limited
1.110
+0.91%
 
0775.HK CKLIFE SCIENCES
0.520
0.00%
 
207940.KS Samsung Biologics Co.,Ltd.
1,146,000.00
-0.95%